Global Epinephrine Injection Market Insights, Forecast to 2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Epinephrine Injection Market Insights, Forecast to 2034
Epinephrine, also known as adrenalin or adrenaline, is a hormone, neurotransmitter and medication. Epinephrine is normally produced by both the adrenal glands and certain neurons. It plays an important role in the fight-or-flight response by increasing blood flow to muscles, output of the heart, pupil dilation, and blood sugar. It does this by its effects on alpha and beta receptors. It is found in many animals and some one-cell organisms. Jokichi Takamine first isolated epinephrine in 1901.
United States has the largest global export quantity and manufacturers in Epinephrine market, while the Europe is the second sales volume market for Epinephrine in 2017.
Market Analysis and InsightsGlobal Epinephrine Injection Market
Global Epinephrine Injection market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Epinephrine Injection industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
Globally, Epinephrine Injection key companies include Mylan Inc, Impax, ALK Abello, Lincoln Medical Ltd, Pfizer, Amphastar, Emerade, Grand Pharma and Harvest Pharmaceuticals, etc. Mylan Inc, Impax, ALK Abello are top 3 players and held % share in total in 2022.
When considering the consumption regions, % revenue of Epinephrine Injection were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029 and the share will be % in 2029. Moreover, China, plays a key role in the whole Epinephrine Injection market and estimated to attract more attentions from industry insiders and investors.
Epinephrine Injection can be divided into Epinephrine Auto-injector, Epinephrine Prefilled Syringe and Combination Epinephrine Products,, etc. Epinephrine Auto-injector is the mainstream product in the market, accounting for % revenue share globally in 2022 and the proportion will be % in 2029.
Epinephrine Injection is widely used in various fields, such as Anaphylaxis, Cardiac Arrest and Others,, etc. Anaphylaxis provides greatest supports to the Epinephrine Injection industry development. In 2022, global % revenue of Epinephrine Injection went into Anaphylaxis filed and the proportion will reach to % in 2029.
Report Covers
This report presents an overview of global Epinephrine Injection market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Epinephrine Injection market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
Mylan Inc
Impax
ALK Abello
Lincoln Medical Ltd
Pfizer
Amphastar
Emerade
Grand Pharma
Harvest Pharmaceuticals
Merit Pharmaceutical
Tianjin Jinyao Group
Segment by Type
Epinephrine Auto-injector
Epinephrine Prefilled Syringe
Combination Epinephrine Products
Anaphylaxis
Cardiac Arrest
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, Epinephrine Injection introduction, etc. Epinephrine Injection Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports Conclusions of Epinephrine Injection
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports
United States has the largest global export quantity and manufacturers in Epinephrine market, while the Europe is the second sales volume market for Epinephrine in 2017.
Market Analysis and InsightsGlobal Epinephrine Injection Market
Global Epinephrine Injection market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Epinephrine Injection industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
Globally, Epinephrine Injection key companies include Mylan Inc, Impax, ALK Abello, Lincoln Medical Ltd, Pfizer, Amphastar, Emerade, Grand Pharma and Harvest Pharmaceuticals, etc. Mylan Inc, Impax, ALK Abello are top 3 players and held % share in total in 2022.
When considering the consumption regions, % revenue of Epinephrine Injection were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029 and the share will be % in 2029. Moreover, China, plays a key role in the whole Epinephrine Injection market and estimated to attract more attentions from industry insiders and investors.
Epinephrine Injection can be divided into Epinephrine Auto-injector, Epinephrine Prefilled Syringe and Combination Epinephrine Products,, etc. Epinephrine Auto-injector is the mainstream product in the market, accounting for % revenue share globally in 2022 and the proportion will be % in 2029.
Epinephrine Injection is widely used in various fields, such as Anaphylaxis, Cardiac Arrest and Others,, etc. Anaphylaxis provides greatest supports to the Epinephrine Injection industry development. In 2022, global % revenue of Epinephrine Injection went into Anaphylaxis filed and the proportion will reach to % in 2029.
Report Covers
This report presents an overview of global Epinephrine Injection market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Epinephrine Injection market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
By Company
Mylan Inc
Impax
ALK Abello
Lincoln Medical Ltd
Pfizer
Amphastar
Emerade
Grand Pharma
Harvest Pharmaceuticals
Merit Pharmaceutical
Tianjin Jinyao Group
Segment by Type
Epinephrine Auto-injector
Epinephrine Prefilled Syringe
Combination Epinephrine Products
Segment by Application
Anaphylaxis
Cardiac Arrest
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, Epinephrine Injection introduction, etc. Epinephrine Injection Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports Conclusions of Epinephrine Injection
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports